Exploratory clinical study of apatinib mesylate tablets in the treatment of EGFR negative patients with non squamous non-small cell lung cancer.
Phase of Trial: Phase IV
Latest Information Update: 22 Nov 2016
At a glance
- Drugs Rivoceranib (Primary) ; Cisplatin; Docetaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 22 Nov 2016 New trial record